article thumbnail

Getting Gelly with It: How Gel Might Transform Cannabis Treatments

Cannabis Life Network

What if I told you that medicinal cannabis could take a new form soon? This upcoming gel might transform cannabis treatments. PreveCeutical, a pharmaceutical company based in Vancouver, recently acquired the rights to commercialize “Sol-Gel” technology.

Treatment 125
article thumbnail

MGC Pharmaceuticals delivers first CannEpil doses to UK patients; opens doors for refractory epilepsy treatment

Cannabis Law Report

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

This authorisation for TSC, represents the fourth approved indication of a cannabis-based medicine in the UK for GW and underlines GW’s commitment to the UK and regulatory approved cannabis-based medicines. “We GW’s pioneering work has led to the regulatory approval of world first, potentially life changing, cannabis-based medicines.

article thumbnail

Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs?

United Patients Group

Cannabis is a natural treatment for pain and other symptoms of withdrawal, and has been shown to help manage the side effects of drugs and even has be used as a substitute for prescription medications. Cannabis is a natural treatment for pain and other symptoms of withdrawal. 3] Cannabis is safer than prescription drugs.

article thumbnail

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.

article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the U.S. territories.

article thumbnail

A.I.-Designed Drugs to Advance Healthcare, Research & Treatment Options

NewsMunchies

AI tools are gaining popularity in biomedical research because while it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, using AI could vastly accelerate the drug-development process. AI automation opens up the possibility of faster, cheaper pharmaceuticals.